BULLFROG AI HOLDINGS, INC. Gain (Loss) on Extinguishment of Debt
BULLFROG AI HOLDINGS, INC. (BFRG) reported Gain (Loss) on Extinguishment of Debt of -$92.96 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2025-03-14
- BULLFROG AI HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2023-12-31 was $0.00.
- BULLFROG AI HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2023-09-30 was $0.00.
- BULLFROG AI HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2023-06-30 was $0.00.
- BULLFROG AI HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2023-03-31 was -$92.96K.
- BULLFROG AI HOLDINGS, INC. gain (loss) on extinguishment of debt for fiscal 2023 was -$92.96K.
- BULLFROG AI HOLDINGS, INC. gain (loss) on extinguishment of debt for fiscal 2021 was $9.92K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $0.00 derived: sum of 2 quarters · filed 2025-03-14 | $0.00 derived: sum of 3 quarters · filed 2025-03-14 | -$92.96K 10-K · filed 2025-03-14 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | -$92.96K 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$92.96K 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$92.96K 10-Q · filed 2024-05-10 | |||
| 2021-12-31 | $9.92K 10-K · filed 2023-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |